News

ORIC Pharmaceuticals to Engage Investors at Major Conferences

ORIC Pharmaceuticals to Engage Investors at Major Conferences

ORIC Pharmaceuticals' Upcoming Investor Conference Engagements

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a promising clinical-stage oncology company, is dedicated to tackling therapeutic resistance in cancer treatment. This June, ORIC is excited to present at key investor conferences designed to connect with industry stakeholders and showcase its innovative approaches to cancer care.

Scheduled Conferences

Management will actively participate in two significant conferences:

Jefferies Global Healthcare Conference

On June 4, 2025, ORIC will engage with investors during a fireside chat at the Jefferies Global Healthcare Conference. This discussion is set to take place at 12:50 p.m. ET, where the company will share insights into its ongoing research and development efforts.

Goldman Sachs 46th Annual Global Healthcare Conference

Following the Jefferies event, ORIC is also slated to present at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, at 10:00 a.m. ET. These conferences present an excellent opportunity for ORIC to communicate its strategies and clinical advancements directly to its investors and analysts.

Webcasts for Investor Accessibility

For those who cannot attend in person, webcasts of these discussions will be available through the investor section of ORIC's official website. Furthermore, replays of these webcasts will be provided for 90 days post-event, ensuring all interested parties can catch up on the insights shared during the presentations.

Company Overview

ORIC Pharmaceuticals is committed to enhancing patient outcomes by Overcoming Resistance In Cancer. The company’s pipeline includes promising drug candidates such as ORIC-944, an innovative allosteric inhibitor designed for the treatment of prostate cancer, and ORIC-114, a drug specifically aimed at targeting genetically defined cancers through its action on EGFR and HER2 mutations.

ORIC's approach combines robust scientific research with clinical development to provide targeted therapies that aim to overcome common cancer resistance mechanisms. By investing in areas of significant unmet medical need, ORIC is positioned to make substantial contributions to the oncology landscape.

Stay Informed with ORIC Pharmaceuticals

ORIC Pharmaceuticals has a dual-base operation in South San Francisco and San Diego, California, reflecting its commitment to being at the forefront of cancer research. For the latest information, updates, and details about ongoing and upcoming projects, interested parties are encouraged to visit the official website and follow ORIC on various social platforms.

Contact Information

For inquiries, please reach out to:
Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com

Frequently Asked Questions

What is the focus of ORIC Pharmaceuticals?

ORIC Pharmaceuticals specializes in developing treatments that target resistance mechanisms in cancer therapies.

When will ORIC participate in the investor conferences?

ORIC will participate in the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Conference on June 10 in 2025.

How can I access ORIC's investor presentations?

Webcasts of the investor presentations will be available on their official website for 90 days after the events.

What are the key products being developed by ORIC?

ORIC is currently developing ORIC-944 for prostate cancer and ORIC-114, targeting specific genetic mutations in different cancers.

Who can I contact for more information about ORIC?

Inquiries can be made through Dominic Piscitelli, CFO, via the provided email addresses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 96

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 65

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 45

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test

Updated Category News Views 53

A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 24

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Surgery Partners Deal Faces Fresh Price Scrutiny Ahead

Updated Category News Views 35

A $23.50 cash offer can look wonderfully tidy until somebody asks how the number was built. That is where Surgery Partners shareholders find themselves after Halper Sadeh LLC said it is investigating the proposed sale of Surgery Partners, Inc. to HealthSpan Partners. The firm is examining whether the company’s board obtained a fair price, ran a conflict-free process,...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 52

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Sailun’s COP31 Pitch Rests on Tire Tech and Hard Proof

Updated Category News Views 113

Antalya Put Tire Chemistry on a Very Public Stage Rubber tires rarely get a starring role at a climate summit, which is exactly why Sailun Group’s appearance at COP31 deserves a closer look. From November 9 through 20 in Antalya, Türkiye, Chairwoman Yanhua Liu used the United Nations climate gathering to lay out the company’s case: better tire technology can cut...

Continue Reading

Top 5 Most Recently Viewed Articles

Renesas Electronics Reveals Optimistic Financial Expectations

Updated Category News Views 68

Renesas Electronics Unveils Future Financial Outlook Renesas Electronics Corporation (TSE: 6723), a leading name in the semiconductor industry, has recently shared its consolidated financial forecasts for the complete fiscal year. This announcement highlights the Group's optimistic projections for the year ending December 31, 2024, despite the inherent volatility seen in...

Continue Reading
Atos Achieves European Leadership in Mainframe Solutions Ranking

Updated Category News Views 213

Atos Secures Top Position in ISG’s Mainframes Evaluation Atos has proudly announced its recognition as a leader in ISG’s Provider Lens™ Mainframes – Services and Solutions for the fourth consecutive year. This accolade highlights Atos' extensive experience, innovative strategies, and commitment to excellence in service delivery. Leadership in Multiple Quadrants In...

Continue Reading
Custom Upholstered Furniture: Comfort Built to Last

Updated Category News Views 150

Rethinking Furniture Comfort: Not Just a Luxury Diving into the world of custom upholstered furniture with insights from Randy Marohn is like finding a cheat sheet for comfort. Seriously, it ain't just about plush cushions or slick fabrics—it's a bonafide science. Marohn, from Sans Furniture Inc. in good ol’ Hamburg, NY, unfolds a tale of intentional design and...

Continue Reading
Cyble Achieves Users' Love Badge With Outstanding Category Wins

Updated Category News Views 84

Cyble Earns G2 'Users Love Us' Badge for Winter 2026 Cyble, a leader in the field of AI-driven cybersecurity and threat intelligence, has recently achieved significant recognition in the G2 Winter 2026 Reports. This includes acquiring the esteemed 'Users Love Us' badge, along with 18 category victories within the domains of threat intelligence, digital risk protection,...

Continue Reading
SunPower Strengthens Sales Force for Future Expansion

Updated Category News Views 210

SunPower Expands Its Sales Force to Drive Future Growth Recently, SunPower Inc. (NASDAQ: SPWR) has made significant strides in expanding its sales force after successfully integrating the sales team from Sunder Energy. The merger promises to boost SunPower's operational effectiveness while setting the stage for unprecedented revenue potential. The company is poised to...

Continue Reading